Search
Levomefolic acid
go.drugbank.com/drugs/DB11256ApprovedLevomefolate is approved as a food additive and is designated a GRAS (generally regarded as safe) compound [L773]. … It is available commercially as a crystalline form of the calcium salt (Metafolin(R)), which has the stability required for use as a supplement [A19276].
Mixtures: BumP DHA, BumP DHABlinatumomab
go.drugbank.com/drugs/DB09052ApprovedInvestigationalIn March 2018, it was approved under the FDA’s accelerated approval program for the treatment of CD19-positive B-cell precursor ALL in first or second complete remission with minimal residual disease ( … a short peptide linker.
Bemotrizinol
go.drugbank.com/drugs/DB11206ApprovedIt primarily absorbs UV-A rays.
Mixtures: Nourishing Day Cream CRème De Jour Nourrissante SPF 15 Fps 15, Refreshing Day Cream CRème De Jour Rafraîchissante SPF 15 Fps 15Molindone
go.drugbank.com/drugs/DB01618ApprovedMolindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors.
Categories: Dopamine D2 Receptor AntagonistsPotassium sulfate
go.drugbank.com/drugs/DB14499ApprovedMixtures: VINATAL DHA CAPSULA DE GELATINA BLANDAGlofitamab
go.drugbank.com/drugs/DB16371ApprovedInvestigational[L45698,A258488] Glofitamab was approved by Health Canada in March 2023 for the treatment of certain patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), becoming the first CD20 … Glofitamab is a full-length bispecific monoclonal antibody with affinity for both CD20 and CD3 surface antigens found on B- and T-cells, respectively.
Tyrosine
go.drugbank.com/drugs/DB00135ApprovedInvestigationalNutraceuticalTyrosine is a non-essential amino acid. In animals it is synthesized from [phenylalanine]. It is also the precursor of [epinephrine], thyroid hormones, and melanin.
Mixtures: Appformin-D, Appbutamone-DIrofulven
go.drugbank.com/drugs/DB05786InvestigationalPhase III clinical trials involving the drug have been underway since early 2001 at sites in the U.S. and Europe. … A novel anti-cancer compound synthesized by scientists at the University of California, San Diego more than a decade ago from toxins of the poisonous jack-o-lantern mushroom, has been granted “fast track
Acetophenazine
go.drugbank.com/drugs/DB01063ApprovedIt primarily targets the dopamine D2 receptor.
Categories: Dopamine D2 Receptor AntagonistsSparteine
go.drugbank.com/drugs/DB06727ApprovedWithdrawnIt is a sodium channel blocker, so it falls in the category of class 1a antiarrhythmic agents. … Sparteine is a plant alkaloid derived from _Cytisus scoparius_ and _Lupinus mutabilis_ which may chelate calcium and magnesium.
Categories: Antiarrhythmics, Class Ia